27 min
Dementia-Related Psychosis in Long-Term Care: Series Part 3 GSA Momentum Discussions
-
- Non-Profit
Individuals with dementia-related psychosis experience worse outcomes than those who do not have psychosis, including but not being limited to accelerated time to being admitted to a long-term care facility and accelerated mortality. The manifestation of hallucinations and delusions in residents with dementia can also prove challenging for long-term care staff. Dr. Chad Worz discusses how appropriate documentation of a diagnosis of dementia-related psychosis and related care interventions are an important part of delivering individualized care for residents.
Guest: Chad Worz, PharmD, BCGPExecutive Director and Chief Operating Officer of the American Society of Consultant Pharmacists (ASCP)
Host: Judit Illes, BCL/LLB, MS, CPHQ Director, Strategic Alliances, The Gerontological Society of America
For more information on dementia-related psychosis, see GSA’s February 2021 White Paper, Dementia-Related Psychosis: Strategies to Address Barriers to Care Across Settings.
This podcast episode is supported by Acadia Pharmaceuticals, Inc. Content was developed by The Gerontological Society of America (GSA).
Individuals with dementia-related psychosis experience worse outcomes than those who do not have psychosis, including but not being limited to accelerated time to being admitted to a long-term care facility and accelerated mortality. The manifestation of hallucinations and delusions in residents with dementia can also prove challenging for long-term care staff. Dr. Chad Worz discusses how appropriate documentation of a diagnosis of dementia-related psychosis and related care interventions are an important part of delivering individualized care for residents.
Guest: Chad Worz, PharmD, BCGPExecutive Director and Chief Operating Officer of the American Society of Consultant Pharmacists (ASCP)
Host: Judit Illes, BCL/LLB, MS, CPHQ Director, Strategic Alliances, The Gerontological Society of America
For more information on dementia-related psychosis, see GSA’s February 2021 White Paper, Dementia-Related Psychosis: Strategies to Address Barriers to Care Across Settings.
This podcast episode is supported by Acadia Pharmaceuticals, Inc. Content was developed by The Gerontological Society of America (GSA).
27 min